BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8094888)

  • 1. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Delannoy A; Hanique G; Ferrant A
    N Engl J Med; 1993 Mar; 328(11):812; author reply 813. PubMed ID: 8094888
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Saven A; Lemon RH; Piro LD
    N Engl J Med; 1993 Mar; 328(11):812-3. PubMed ID: 8094889
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-Chlorodeoxyadenosine (2-CdA) in chronic lymphocytic leukemia refractory to fludarabine?
    Schirmer M; Michlmayr G; Geisen F; Konwalinka G
    Leukemia; 1996 Jul; 10(7):1253-4. PubMed ID: 8684013
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Juliusson G; Elmhorn-Rosenborg A; Liliemark J
    N Engl J Med; 1992 Oct; 327(15):1056-61. PubMed ID: 1355853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
    Saven A; Piro L
    N Engl J Med; 1994 Jun; 330(25):1829-30. PubMed ID: 7910665
    [No Abstract]   [Full Text] [Related]  

  • 6. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
    Juliusson G; Liliemark J
    N Engl J Med; 1994 Jun; 330(25):1828-9; author reply 1829-30. PubMed ID: 7910664
    [No Abstract]   [Full Text] [Related]  

  • 7. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
    Saven A
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614
    [No Abstract]   [Full Text] [Related]  

  • 8. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C; Hiddemann W
    Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current results and prospective trials of cladribine in chronic lymphocytic leukemia.
    Tallman MS; Hakimian D
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):23-7. PubMed ID: 8714613
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy.
    O'Brien S; Kantarjian H; Estey E; Koller C; Robertson B; Beran M; Andreeff M; Pierce S; Keating M
    N Engl J Med; 1994 Feb; 330(5):319-22. PubMed ID: 7904047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listeriosis after 2-chlorodeoxyadenosine treatment.
    Spielberger RT; Stock W; Larson RA
    N Engl J Med; 1993 Mar; 328(11):813-4. PubMed ID: 8094890
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of chronic lymphatic leukemia].
    Adam Z; Vorlícek J; Hejlová N
    Vnitr Lek; 1996 Aug; 42(8):573-8. PubMed ID: 8967031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs in the treatment of chronic lymphocytic leukemia.
    Keating MJ; O'Brien S; Robertson L; Plunkett W; Kantarjian H; Koller C
    Leukemia; 1992 Nov; 6 Suppl 4():140-1. PubMed ID: 1359203
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy for previously untreated chronic lymphocytic leukemia: a reevaluation.
    Cheson BD
    Semin Hematol; 1998 Jul; 35(3 Suppl 3):14-21. PubMed ID: 9685175
    [No Abstract]   [Full Text] [Related]  

  • 15. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
    Bouzar AB; Boxus M; Defoiche J; Berchem G; Macallan D; Pettengell R; Willis F; Burny A; Lagneaux L; Bron D; Chatelain B; Chatelain C; Willems L
    Br J Haematol; 2009 Jan; 144(1):41-52. PubMed ID: 19006566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 17. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine approved for use in chronic lymphocytic leukemia.
    Oncology (Williston Park); 1991 Jun; 5(6):20. PubMed ID: 1831638
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
    Morabito F; Stelitano C; Callea I; Filangeri M; Oliva B; Sculli G; Callea V; Nobile F; Brugiatelli M
    Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful treatment for advanced and refractory chronic lymphocytic leukemia with fludarabine phosphate].
    Takeuchi M; Tada A; Soda R; Takahashi K
    Rinsho Ketsueki; 1997 Sep; 38(9):792-4. PubMed ID: 9364873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.